Keytruda

John Key says his budget boost for Pharmac should be enough to get a melanoma drug over the line, after the Pharmac CEO says it wouldn't fund Keytruda even if it had the money. Let's unpack this...

How high is "quite high"?

That's a life and death question having heard both the Pharmac CEO Steffan Crausaz and Prime Minister talk about funding a melanoma drug over the past 48 hours.